deltatrials
Terminated PHASE4 INTERVENTIONAL 2-arm NCT00401960

Daptomycin as an Adjuvant Agent in the Treatment of Enterococcal Native Valve Endocarditis.

Open Label Study to Assess the Efficacy and Safety of Daptomycin in Combination With Anti-Cell Wall Active Therapy in the Treatment of Enterococcal Endocarditis

Sponsor: Weill Medical College of Cornell University

Conditions Endocarditis, Bacterial
Interventions Daptomycin
Updated 8 times since 2017 Last updated: Apr 6, 2017 Started: Sep 30, 2006 Primary completion: Oct 31, 2008 Completion: Oct 31, 2008
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

inadequate enrollment

Other terminated trials from Weill Medical College of Cornell University

See all terminations from Weill Medical College of Cornell University

Other Endocarditis, Bacterial trials with similar outcome

Browse all Endocarditis, Bacterial trials

Listed as NCT00401960, this PHASE4 trial focuses on Endocarditis, Bacterial and remains terminated or withdrawn. Sponsored by Weill Medical College of Cornell University, it has been updated 8 times since 2006, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotTerminated~Feb 2017 – ~Jun 2017 · 4 months · monthly snapshotTerminated~Jun 2017 – ~Jun 2018 · 12 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotTerminated~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE4

  3. Dec 2021 — Jul 2024 [monthly]

    Terminated PHASE4

  4. Jan 2021 — Dec 2021 [monthly]

    Terminated PHASE4

  5. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE4

▶ Show 3 earlier versions

  1. Jun 2017 — Jun 2018 [monthly]

    Terminated PHASE4

  2. Feb 2017 — Jun 2017 [monthly]

    Terminated PHASE4

  3. Jan 2017 — Feb 2017 [monthly]

    Terminated PHASE4

    First recorded

Sep 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Weill Medical College of Cornell University
Data source: Weill Medical College of Cornell University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations